Overview
Molly Wolfe is an associate in the Litigation practice of Paul Hastings and is based in the firm's New York office. Her practice focuses on all aspects of commercial litigation and white collar investigations. Ms. Wolfe has experience representing clients in civil and criminal securities fraud matters involving market manipulation and insider trading, as well as inquiries by government entities such as the Department of Justice and the Securities and Exchange Commission. Ms. Wolfe also handles internal investigations, including in relation to the False Claims Act, the Foreign Corrupt Practices Act, and whistleblower claims.
Ms. Wolfe received her law degree from Columbia Law School in 2018, where she served as a Notes Editor for the Journal of Law and Social Problems. She earned a Bachelor of Arts degree in Philosophy and History, magna cum laude, from Boston College in 2012.
Ms. Wolfe is admitted to practice law in New York.
Representations
- In May 2020, was part of the team that defeated a preliminary injunction to allow our client to proceed with a UCC sale of pledged membership interests in connection with a defaulted mezzanine construction loan on a New York City project, becoming the first case in which a New York state court interpreted the terms of Governor Cuomo's Executive Orders enacted at the outset of the COVID-19 pandemic while New York remained in a state of disaster emergency.
- Representing a foreign corporation in resolving charges under the FCPA.
- Representing two hedge funds in a securities fraud action arising out of a series of private placements by a global shipping company.
- Representing a public company in connection with a related party and disclosure investigation by the SEC.
- Representing a biotech company in connection with potential whistleblower allegations relating to clinical trial and regulatory compliance matters.
- Represented a foreign exchange trader in connection with an investigation by the DOJ into alleged currency market manipulation related to swaps trading.
insights
- Rapid Rulemaking: A Look at the Securities and Exchange Commission’s Recent Proposed Rules - March 25th, 2022
- SEC Charges SPAC, Sponsor, Merger Target, and CEOs—Claims SPAC Failed to Conduct Sufficient Due Diligence and Obtains Forfeiture of Founder’s Shares - July 19th, 2021
- New York Appellate Division Wades into Cyan’s Waters with Two New Decisions - December 15th, 2020
- Delaware Supreme Court Clarifies Elements of Disclosure Claims in Limited Partner Context - June 29th, 2020
- The Duties of Directors for Overseeing Business Risks During a Pandemic - April 24th, 2020
- ISDA Derivatives and Communicating Notice - April 20th, 2020
- Derivativos sob padrão ISDA e Notificação - April 20th, 2020
- COVID-19 Alert — Good Faith and the Corporate Disclosure: An SEC Enforcement and Litigation Perspective - April 10th, 2020
- Delaware Supreme Court Validates Federal Forum Provisions: A Solution to the Explosion of State Court Securities Act Litigation? - March 19th, 2020